Basics EyePoint Pharmaceuticals, Inc. Common Stock IPO Date: February 1, 2005 Sector: Healthcare Industry: Pharma Market Cap: $1.47B Activated in VL: True Average Daily Range Avg Daily Range: $0.27 | 3.77% Avg Daily Range (30 D): $0.52 | 4.01% Avg Daily Range (90 D): $0.41 | 3.29% Institutional Daily Volume Avg Daily Volume: .59M Avg Daily Volume (30 D): 1.07M Avg Daily Volume (90 D): .93M Trade Size Avg Trade Size (Sh.): 121 Avg Trade Size (Sh.) (30 D): 69 Avg Trade Size (Sh.) (90 D): 71 Institutional Trades Total Inst.Trades: 831 Avg Inst. Trade: $1.53M Avg Inst. Trade (30 D): $1.45M Avg Inst. Trade (90 D): $1.33M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.52M Avg Closing Trade (30 D): $1.39M Avg Closing Trade (90 D): $1.37M Avg Closing Volume: 121.66K     News Nov 19, 2025 @ 12:00 PM EyePoint Announces Positive Recommendation from In... Source: Eyepoint Pharmaceuticals Nov 5, 2025 @ 12:00 PM EyePoint Reports Third Quarter 2025 Financial Resu... Source: Eyepoint Pharmaceuticals Oct 15, 2025 @ 2:43 AM EyePoint Announces Pricing of Public Offering Source: Eyepoint Pharmaceuticals, Inc. Aug 26, 2025 @ 11:00 AM EyePoint Announces Participation at Upcoming Inves... Source: Eyepoint Pharmaceuticals, Inc. Jul 30, 2025 @ 11:00 AM EyePoint to Report Second Quarter 2025 Financial R... Source: Eyepoint Pharmaceuticals Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.85 $-.85 $-.65 Diluted EPS $-.85 $-.85 $-.65 Revenue $ .97M $ 5.33M $ 24.45M Gross Profit $ $ $ Net Income / Loss $ -59.73M $ -59.43M $ -45.2M Operating Income / Loss $ -62.03M $ -62.23M $ -48.84M Cost of Revenue $ $ $ Net Cash Flow $ 3.43M $ -14.02M $ -14.55M PE Ratio     Splits Dec 09, 2020:   1:10 Jun 11, 2008:   1:4